Serious Mental Illness: Conference Sessions

MGH 50th Annual Psychopharmacology Conference

October 16–18, 2026 · Boston, MA

• SessionProdromes, Early Detection and Prevention of Major Psychiatric Illnesses

  Daphne Holt

  Evening seminar on identifying and intervening in the earliest stages of serious mental illness.

  Schizophrenia & Psychosis

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA

• LecturePeer Support for Transition-Age Youth With Severe Mood Disorders: Preliminary Outcomes of the STEAM Project

  Memphis Kastner · Erin Belback · Danella Hafeman

  Reports preliminary outcomes of a peer support program for transition-age youth with severe mood disorders.

  Child & AdolescentDepression

• LectureEmpowering Staff for Quality Residential Care

  Terry Git Lee

  Looks at empowering staff to deliver quality care in residential treatment settings.

  Child & AdolescentPractice, Policy & Workforce

• LectureFamily Engagement and Discharge Planning

  Kalyani Samudra · Heather Smith

  Covers family engagement and discharge planning in residential treatment.

  Child & Adolescent

• LectureMelting the Snowball Before It Reaches the Bottom of the Hill: Role of Primary and Secondary Prevention in Residential Treatment

  Stephen Mateka

  Examines primary and secondary prevention approaches within residential treatment.

  Child & Adolescent

• LectureLongitudinal Outcomes for Patients Beyond the First 2 Years in an Early Psychosis Program: Should They Stay, or Should They Go?

  Ramin Mojtabai

  Looks at long-term patient outcomes beyond the standard two-year period in an early psychosis program and whether to continue or end care.

  Schizophrenia & Psychosis

See all 15 serious mental illness sessions at this meeting →

NEI Fall Congress 2026

November 5–8, 2026 · Colorado Springs, CO

• SymposiumTime Is Brain: Early Adoption of Long-Acting Injectables to Improve Functional Outcomes in Serious Mental Illness

  Christoph U. Correll

  Makes the case for earlier use of long-acting injectable antipsychotics in serious mental illness, with shared decision-making strategies.

  Antipsychotic PrescribingLong-Acting Injectables

• SymposiumFrom Stigma to Superpower: Reframing Mental Health Disorders Through Creativity and Contribution

  Andrew J. Cutler · Roger S. McIntyre

  Explores reframing mental illness by highlighting creativity and societal contribution of people with psychiatric conditions.

  Diverse & Underserved Populations

AAAP 37th Annual Meeting and Scientific Symposium

November 12–15, 2026 · Memphis, TN

• WorkshopCOMMITTED: A New PBS Series on Outpatient Commitment

  Kenneth Rosenberg · Alison Breaux · David Pool · Steven Foglesong · Laurence Westreich

  Screens and discusses a PBS documentary series on outpatient commitment, with perspectives from psychiatrists, judges, and law enforcement.

  Emergency & Acute PsychiatryForensic & Correctional

• SymposiumMini Symposium - Tobacco Use and Its Impact on Psychiatric Symptoms and the Recovery from Other Substance Use Disorders

  Maher Karam Hage · Jill Williams · Brian Hurley · Tony George

  Covers the interplay between tobacco use and psychiatric symptoms, and how continued smoking affects recovery from other substance use disorders.

  Substance Use Disorders

• WorkshopCourt-supervised Outpatient Commitment: Judges, Doctors, and Police discuss a case from PBS film

  Kenneth Rosenberg · Alison Breaux · David Pool · Steven Foglesong · Laurence Westreich

  Judges, physicians and police discuss court-supervised outpatient commitment using a case from a PBS film.

  Forensic & Correctional

• Oral abstractLong-Acting Injectable Antipsychotics in Serious Mental Illness with Co-Occurring Substance Use: A Retrospective Cohort Study

  Kathryn Renard

  Cohort study of long-acting injectable antipsychotic use in patients with serious mental illness and substance use.

  Long-Acting InjectablesSubstance Use Disorders

• Oral abstractSerious Mental Illness and Outcomes in Inpatient Detoxification and Rehabilitation: A Retrospective Cohort Study

  Sean Lynch

  Cohort study of how serious mental illness affects inpatient detoxification and rehabilitation outcomes.

  Substance Use Disorders

See all 7 serious mental illness sessions at this meeting →

Substance Use Disorders: A Comprehensive Review and Update 2027

February 15–17, 2027 · Lake Buena Vista, FL

• LecturePeer Support and Residential Communities

  David Eddie

  Reviews peer support and residential recovery communities as supports for people in recovery.

  Substance Use Disorders

39th ECNP Congress

October 10–13, 2026 · Munich, Germany

• SymposiumS22 – Excess mortality in people with mental health problems – influence of comorbidity

  Elias Wagner · Ana Jiménez Peinado · Toby Pillinger · J. John Mann

  Evidence on premature mortality in anxiety, bipolar disorder, and schizophrenia, and the role of physical comorbidity and inflammation.

  Inflammation & ImmunopsychiatrySchizophrenia & PsychosisMedical Comorbidity & C-L Psychiatry

WCP 2026 — 26th World Congress of Psychiatry

September 23–26, 2026 · Stockholm, Sweden

• SymposiumState of the Art Symposium 07: Mental Health Systems, Access, and Rehabilitation

  Practice, Policy & Workforce

• SymposiumPresidential Symposium: Challenges for Psychiatric Rehabilitation